CLINICAL_TRIALS ClinicalTrials.gov record update

A Remote-Directed "Virtual" Clinical Trial in Metastatic Solid Tumors to Determine Feasibility of Evaluating Patient Response to Immunotherapy Using Spliceosome Mutational Markers (PRISMM)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04447651
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:35.618327+00:00
Published At: 2025-07-14T00:00:00+00:00
Record Updated At: 2025-07-14
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Metastatic Solid Tumor", "SF3B1 Gene Mutation", "Spliceosome Mutation", "U2AF1 Gene Mutation", "SRSF2 Gene Mutation"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-07-14"
protocolSection.identificationModule.nctId: "NCT04447651"
protocolSection.identificationModule.officialTitle: "A Remote-Directed \"Virtual\" Clinical Trial in Metastatic Solid Tumors to Determine Feasibility of Evaluating Patient Response to Immunotherapy Using Spliceosome Mutational Markers (PRISMM)"
protocolSection.statusModule.overallStatus: "ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.